Acadia Pharmaceuticals Inc. logo

Acadia Pharmaceuticals Inc. (ACAD)

Market Closed
28 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
22. 62
-0.63
-2.71%
$
3.73B Market Cap
- P/E Ratio
0% Div Yield
1,736,216 Volume
-0.34 Eps
$ 23.25
Previous Close
Day Range
22.58 23.26
Year Range
13.4 25.23
Want to track ACAD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 2 days
Acadia Pharmaceuticals Inc. logo
ACAD Acadia Pharmaceuticals Inc.
6 Aug 2025 (In 1 week)
0.14
Cons. EPS
-
EPS
Acadia Pharmaceuticals Inc. logo
ACAD Acadia Pharmaceuticals Inc.
5 Aug 2025 (In 1 week)
0.14
Cons. EPS
-
EPS
Acadia Pharmaceuticals Inc. logo
ACAD Acadia Pharmaceuticals Inc.
30 Jul 2025 (In 2 days)
0.14
Cons. EPS
-
EPS
Acadia Pharmaceuticals Inc. logo
ACAD Acadia Pharmaceuticals Inc.
6 May 2025
0.05
Cons. EPS
0.11
EPS
Acadia Pharmaceuticals Inc. logo
ACAD Acadia Pharmaceuticals Inc.
25 Feb 2025
0.22
Cons. EPS
0.86
EPS
Acadia Pharmaceuticals Inc. logo
ACAD Acadia Pharmaceuticals Inc.
6 Nov 2024
0.14
Cons. EPS
0.2
EPS
Acadia Pharmaceuticals Inc. logo
ACAD Acadia Pharmaceuticals Inc.
31 Oct 2024
-
Cons. EPS
-
EPS
Acadia Pharmaceuticals Inc. logo
ACAD Acadia Pharmaceuticals Inc.
6 Aug 2024
0.18
Cons. EPS
0.2
EPS
Acadia Pharmaceuticals Inc. logo
ACAD Acadia Pharmaceuticals Inc.
31 Jul 2024
0.19
Cons. EPS
-
EPS
Acadia Pharmaceuticals Inc. logo
ACAD Acadia Pharmaceuticals Inc.
29 May 2024
0.05
Cons. EPS
-
EPS
Acadia Pharmaceuticals Inc. logo
ACAD Acadia Pharmaceuticals Inc.
8 May 2024
0.05
Cons. EPS
0.1
EPS
Acadia Pharmaceuticals Inc. logo
ACAD Acadia Pharmaceuticals Inc.
27 Feb 2024
0.3
Cons. EPS
0.28
EPS
Acadia Pharmaceuticals Inc. logo
ACAD Acadia Pharmaceuticals Inc.
2 Nov 2023
-
Cons. EPS
-
EPS
Acadia Pharmaceuticals Inc. logo
ACAD Acadia Pharmaceuticals Inc.
7 Nov 2016
-
Cons. EPS
-
EPS
Acadia Pharmaceuticals Inc. logo
ACAD Acadia Pharmaceuticals Inc.
4 Aug 2016
-
Cons. EPS
-
EPS
Acadia Pharmaceuticals Inc. logo
ACAD Acadia Pharmaceuticals Inc.
5 May 2016
-
Cons. EPS
-
EPS
Acadia Pharmaceuticals Inc. logo
ACAD Acadia Pharmaceuticals Inc.
29 Feb 2016
-
Cons. EPS
-
EPS
Acadia Pharmaceuticals Inc. logo
ACAD Acadia Pharmaceuticals Inc.
5 Nov 2015
-
Cons. EPS
-
EPS
Acadia Pharmaceuticals Inc. logo
ACAD Acadia Pharmaceuticals Inc.
6 Aug 2015
-
Cons. EPS
-
EPS
Acadia Pharmaceuticals Inc. logo
ACAD Acadia Pharmaceuticals Inc.
7 May 2015
-
Cons. EPS
-
EPS
Acadia Pharmaceuticals Inc. logo
ACAD Acadia Pharmaceuticals Inc.
26 Feb 2015
-
Cons. EPS
-
EPS
Acadia Pharmaceuticals Inc. logo
ACAD Acadia Pharmaceuticals Inc.
10 Nov 2014
-
Cons. EPS
-
EPS
Acadia Pharmaceuticals Inc. logo
ACAD Acadia Pharmaceuticals Inc.
5 Aug 2014
-
Cons. EPS
-
EPS
Acadia Pharmaceuticals Inc. logo
ACAD Acadia Pharmaceuticals Inc.
6 May 2014
-
Cons. EPS
-
EPS
Acadia Pharmaceuticals Inc. logo
ACAD Acadia Pharmaceuticals Inc.
27 Feb 2014
-
Cons. EPS
-
EPS
Acadia Pharmaceuticals Inc. logo
ACAD Acadia Pharmaceuticals Inc.
6 Nov 2013
-
Cons. EPS
-
EPS
Acadia Pharmaceuticals Inc. logo
ACAD Acadia Pharmaceuticals Inc.
6 Aug 2013
-
Cons. EPS
-
EPS
Acadia Pharmaceuticals Inc. logo
ACAD Acadia Pharmaceuticals Inc.
7 May 2013
-
Cons. EPS
-
EPS
Acadia Pharmaceuticals Inc. logo
ACAD Acadia Pharmaceuticals Inc.
12 Mar 2013
-
Cons. EPS
-
EPS

ACAD Earnings Reports FAQ

What is the earnings per share (EPS) for ACAD?

The current EPS is -0.34.

What is the company's earnings growth rate?

Over the past 12 years, the earnings growth rate has been approximately -60.71%, reflecting the ACAD's performance and NASDAQ (NGS) market conditions.

When is the next earnings release date?

The next earnings release is expected to be on 2025-07-30, based on the ACAD's typical earnings announcement schedule.